Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.

All technologies
 are listed as non-confidential technical summaries.

Technologies were generated by academic institutions, entrepreneurs, and corporations.

Click the Tech Search button below to have Whiteboard 2 Boardroom® staff complete a personalized search for innovations to license from our research institution partners.

The most recent innovations from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available. 

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Gene Therapy for Pancreatic Cancer

Researchers at the University of Missouri have discovered a novel target for the treatment of pancreatic cancer.  Using gene therapy they have demonstrated effective treatment of pancreatic cancer in animal models of this difficult to treat disease.  This discovery promises to offer new therapeutic options where convention treatments often fail.
Pancreatic cancer is the fourth leading cause of cancer death in the US.  Conventional cancer therapies such as chemotherapy and radiation are often ineffective, as pancreatic cancer is usually not detected until after it has metastasized.  This leaves approximately 80% of pancreatic cancer patients with no options for effective treatment.
Inventors at the University of Missouri, have identified a novel target demonstrated to be effective at treating pancreatic cancer.  In vivo mouse model data demonstrate effective 10x reduction of tumor load.
- Pancreatic cancer treatment (especially where chemotherapy and surgery fail)
- Potential application to other cancer types (to be tested)

- An alternative to chemotherapy, surgery, and other treatment options that are often ineffective
- Uses FDA-approved methods
- Novel target for treatment of pancreatic cancer
State of Development
Early stage, preclinical, translational studies are in progress

Additional Details


University of Missouri-Columbia

Intellectual Property Protection

Pending Patent

Interested? Request More Information